All Clinical & Diagnostics articles – Page 2
-
NewsPhase 2 clinical trial results show potential to shorten TB treatment time
New clinical trial results show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, has the potential to improve tuberculosis (TB) treatment when combined with pretomanid and linezolid in a treatment regimen known as “SPaL.”
-
NewsBiomedical Sciences researcher receives nearly $7 million in federal grants to fight STIs
Cynthia Nau Cornelissen, a Distinguished University Professor and associate director of the Institute for Biomedical Sciences at Georgia State University, has received nearly $7 million in two, five-year federal grants to develop vaccines and therapeutics to combat sexually transmitted infections (STIs).
-
NewsExperts urge continued hepatitis B vaccine birth doses for newborns
In a new commentary, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth. Hepatitis B vaccines are safe and effective with over one billion doses administered worldwide.
-
NewsNew test could speed detection of three serious regional fungal infections
Researchers have developed a new molecular test capable of detecting three major pathogenic fungi at once — and with a much quicker turnaround than traditional methods.
-
NewsNew test could allow for more accurate Lyme disease diagnosis
Researchers have developed a new way to detect the Lyme disease bacterium Borrelia burgdorferi, allowing for faster and more accurate diagnosis.
-
NewsTyphoid conjugate vaccine demonstrates strong safety and immunogenicity: Results from Phase 3 study
PATH and EuBiologics Co., LTD have announced Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.® Source: CDC/ Armed Forces Institute of Pathology, Charles N. Farmer This photomicrograph reveals some of the histopathology exhibited in a lymph node tissue ...
-
NewsRepurposed antibiotic shows promise against Central Nervous System Tuberculosis
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated that doxycycline, a commonly available and inexpensive antibiotic, can improve survival rates and neurological outcomes in Central Nervous System Tuberculosis (CNS-TB) in a preclinical non-human study. Published in the Journal of Neuroinflammation, the ...
-
NewsBlood-based immunological signatures for extrapulmonary tuberculosis decoded
Scientists have deciphered the immunological properties of extrapulmonary tuberculosis (EPTB) in the blood of affected patients. The results may help to develop new targeted treatments and tests for this important disease.
-
NewsNo-needle test can tell if flu/COVID vaccines are effective
A team of researchers has developed a skin patch that can detect antibodies associated with COVID and flu infections. It’s orders of magnitude more sensitive than existing tests, uses just a half volt of electricity, and can return results in 10 minutes.
-
NewsHorizon Awards 2025: Professor Elaine Cloutman-Green named as winner of Christiana Figueres Policy to Practice Award
Professor Elaine Cloutman-Green, Consultant Clinical Scientist at Great Ormond Street Hospital, has been named as the newest winner of the Christiana Figueres Policy to Practice Award.
-
NewsScientists develop novel gene therapy for hereditary hearing loss
Scientists have introduced an innovative gene therapy method to treat impairments in hearing and balance caused by inner ear dysfunction. The treatment holds promise for treating a wide range of mutations that cause hearing loss.
-
NewsScientists identify cells by seeing how high they levitate
A new cell-sorting device uses electromagnetic levitation to precisely direct the movement of cells. It can be used to separate different types of cells — cancer cells from healthy cells, or live cells from dead cells, for example — with many potential applications in the lab and in the clinic.
-
NewsSpectral signatures reveal hidden pine defenses: New tech enhances fusiform rust Resistance screening
A research team has developed a novel way to detect disease resistance in loblolly pine (Pinus taeda L.) using near-infrared (NIR) spectroscopy, offering a faster and more objective alternative to traditional visual inspection.
-
NewsBay Area Lyme Foundation opens applications for 2026 Emerging Leader Awards and research grants
Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, has announced its call for applicants from academia and the private sector for the 2026 Emerging Leader Awards (ELA).
-
NewsAI tool beats humans at detecting parasites in stool samples, study finds
Scientists have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose parasitic infections around the world.
-
NewsBruker announces FDA Clearance of Claims 7 and 8 for the MALDI Biotyper® CA System
Bruker has announced FDA clearance of Claim 7 and Claim 8 for its MALDI Biotyper® CA System, marking a significant advancement in clinical microbial identification capabilities.
-
NewsAll-in-one POM-based nanoreactor with oxidase-like activity for versatile detection and antibacterial action
A research team has developed a novel nanoreactor that enables dual-mode biomarker detection and effective antibacterial treatment.
-
NewsHuman Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies
Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy.
-
NewsGut microbiota disruption predicts severe steatosis in MASLD patients
A new study links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic liver disease (MASLD). In a 61-patient cohort, those with the inflammation-linked Bact2 enterotype developed severe steatosis at lower thresholds.
-
NewsResearchers developing new easy-to-use viral biosensor test, giving patients more accurate and immediate results
An interdisciplinary team of researchers is creating a single low-cost test to detect HIV & Hepatitis B and C simultaneously, that may be used in resource-limited settings. With quicker and more accessible results, the test has potential to save lives.